tradingkey.logo
tradingkey.logo
Search

Novavax up; Shah Capital to vote against board, exec pay

ReutersApr 8, 2026 10:21 AM
facebooktwitterlinkedin

Shares of vaccine maker Novavax NVAX.O rise 6.1% to $8.47 premarket

Activist investor Shah Capital plans to vote against the re-election of board nominees and the executive compensation package at Novavax's upcoming annual meeting

In a letter sent Wednesday, Shah Capital founder Himanshu Shah criticizes management for failing to implement aggressive cost-cutting measures

Investor urges company to slash expenses and opportunistically repurchase 10–20 mln shares

Shah Capital owns about 9% of Novavax, making it the company’s second-largest shareholder

Hedge fund has been pressing the board to pursue strategic alternatives, including a potential sale of the biotech firm

As of last close, stock up 18.8% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI